Agree. Good news is easy to draft.....bad not so. The share that just keeps on...........disappointing. sigh...
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago